Haemonetics Corp. (HAE)
72.17
-1.83
(-2.47%)
USD |
NYSE |
Jan 16, 16:00
72.14
-0.03
(-0.04%)
After-Hours: 20:00
Haemonetics Shareholders Equity (Quarterly): 849.17M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 50.95B |
| Solventum Corp. | 4.986B |
| DexCom, Inc. | 2.726B |
| Masimo Corp. | 810.00M |
| UFP Technologies, Inc. | 403.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.442B |
| Total Liabilities (Quarterly) | 1.593B |
| Debt to Equity Ratio | 1.442 |
| Current Ratio | 1.641 |
| Net Debt Paydown Yield | -0.01% |